Rituximab Versus Cyclophosphamide for Remission Induction in Active, Severe Antineutrophil Cytoplasmic Antibody–associated Vasculitis: Comment on the Article by Chung Et Al
Arthritis & rheumatology(2022)
摘要
Disclosureform Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要